Literature DB >> 32427033

Analytical techniques for multiplex analysis of protein biomarkers.

Alain Van Gool1, Fernado Corrales2, Mirjana Čolović3, Danijela Krstić4, Begona Oliver-Martos5, Eva Martínez-Cáceres6, Ivone Jakasa7, Goran Gajski8, Virginie Brun9, Kyriacos Kyriacou10, Izabela Burzynska-Pedziwiatr11, Lucyna Alicja Wozniak11, Stephan Nierkens12, César Pascual García13, Jaroslav Katrlik14, Zanka Bojic-Trbojevic15, Jan Vacek16, Alicia Llorente17, Felicia Antohe18, Viorel Suica18, Guillaume Suarez19, Ruben t'Kindt20, Petra Martin21, Deborah Penque22, Ines Lanca Martins22, Ede Bodoki23, Bogdan-Cezar Iacob23, Eda Aydindogan24, Suna Timur25, John Allinson26, Christopher Sutton27, Theo Luider28, Saara Wittfooth29, Marei Sammar30.   

Abstract

INTRODUCTION: The importance of biomarkers for pharmaceutical drug development and clinical diagnostics is more significant than ever in the current shift toward personalized medicine. Biomarkers have taken a central position either as companion markers to support drug development and patient selection, or as indicators aiming to detect the earliest perturbations indicative of disease, minimizing therapeutic intervention or even enabling disease reversal. Protein biomarkers are of particular interest given their central role in biochemical pathways. Hence, capabilities to analyze multiple protein biomarkers in one assay are highly interesting for biomedical research. AREAS COVERED: We here review multiple methods that are suitable for robust, high throughput, standardized, and affordable analysis of protein biomarkers in a multiplex format. We describe innovative developments in immunoassays, the vanguard of methods in clinical laboratories, and mass spectrometry, increasingly implemented for protein biomarker analysis. Moreover, emerging techniques are discussed with potentially improved protein capture, separation, and detection that will further boost multiplex analyses. EXPERT COMMENTARY: The development of clinically applied multiplex protein biomarker assays is essential as multi-protein signatures provide more comprehensive information about biological systems than single biomarkers, leading to improved insights in mechanisms of disease, diagnostics, and the effect of personalized medicine.

Entities:  

Keywords:  Multiplexing; mass spectrometry; validation

Mesh:

Substances:

Year:  2020        PMID: 32427033     DOI: 10.1080/14789450.2020.1763174

Source DB:  PubMed          Journal:  Expert Rev Proteomics        ISSN: 1478-9450            Impact factor:   3.940


  12 in total

1.  New "Omics" Approaches as Tools to Explore Mechanistic Nanotoxicology.

Authors:  Célia Ventura; Vukosava Torres; Luís Vieira; Bruno Gomes; António Sebastião Rodrigues; José Rueff; Deborah Penque; Maria João Silva
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

2.  Bile Processing Protocol for Improved Proteomic Analysis.

Authors:  Sergio Ciordia; Gloria Alvarez-Sola; María Rullán; Jesús M Urman; Matías A Ávila; Fernando J Corrales
Journal:  Methods Mol Biol       Date:  2022

Review 3.  Multiplex protein analysis for the study of glaucoma.

Authors:  Gülgün Tezel
Journal:  Expert Rev Proteomics       Date:  2021-10-29       Impact factor: 3.940

4.  Urinary Angiogenin as a Marker for Bladder Cancer: A Meta-Analysis.

Authors:  Amir Hossein Aalami; Hossein Abdeahad; Mohammad Mesgari; Thozhukat Sathyapalan; Amirhossein Sahebkar
Journal:  Biomed Res Int       Date:  2021-04-27       Impact factor: 3.411

Review 5.  Enzymatic Methods for Salivary Biomarkers Detection: Overview and Current Challenges.

Authors:  Alonso Ornelas-González; Margarita Ortiz-Martínez; Mirna González-González; Marco Rito-Palomares
Journal:  Molecules       Date:  2021-11-20       Impact factor: 4.411

6.  Comparison of two multiplexed technologies for profiling >1,000 serum proteins that may associate with tumor burden.

Authors:  Annie Ren; Ioannis Prassas; Vijithan Sugumar; Antoninus Soosaipillai; Marcus Bernardini; Eleftherios P Diamandis; Vathany Kulasingam
Journal:  F1000Res       Date:  2021-06-28

Review 7.  Uncovering the Depths of the Human Proteome: Antibody-based Technologies for Ultrasensitive Multiplexed Protein Detection and Quantification.

Authors:  Annie H Ren; Eleftherios P Diamandis; Vathany Kulasingam
Journal:  Mol Cell Proteomics       Date:  2021-09-28       Impact factor: 7.381

Review 8.  Immune Monitoring After Allogeneic Hematopoietic Cell Transplantation: Toward Practical Guidelines and Standardization.

Authors:  Jaap Jan Boelens; Kinga K Hosszu; Stefan Nierkens
Journal:  Front Pediatr       Date:  2020-08-21       Impact factor: 3.418

9.  The New and the Old: Platform Cross-Validation of Immunoaffinity MASS Spectrometry versus ELISA for PromarkerD, a Predictive Test for Diabetic Kidney Disease.

Authors:  Scott Bringans; Kirsten Peters; Tammy Casey; Jason Ito; Richard Lipscombe
Journal:  Proteomes       Date:  2020-10-28

Review 10.  Novel Approaches to an Integrated Route for Trisomy 21 Evaluation.

Authors:  Angelika Buczyńska; Iwona Sidorkiewicz; Anna Trochimiuk; Sławomir Ławicki; Adam Jacek Krętowski; Monika Zbucka-Krętowska
Journal:  Biomolecules       Date:  2021-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.